Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Cytomegalovirus Infection in Bone Marrow-Derived Mesenchymal Stem Cells: Implications for Functions and Exploration of Relevant Mechanisms

Weiran Lv, Zhiping Fan, MD, Fen Huang, MD, Na Xu, MD, Li Xuan, MD, Ren Lin, MD, Ke Zhao, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 5005.

https://doi.org/10.1182/blood-2019-125318

Published: 2019

Journal Articles

Pre-Emptive Tyrosine Kinase-Inhibitor Intervention Based on BCR/ABL1 Monitoring in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allo-HSCT: Two Independent Observational Cohort Study

Liu Hui, MD, Li Xuan, MD, Ren Lin, MD, Lan Deng, MD PhD, Fen Huang, MD, Zhiping Fan, MD, Danian Nie, MD, Xudong Li, Xinquan Liang, Dan Xu, Yu Zhang, Na Xu, MD, Jieyu Ye, MD PhD, Hua Jin, Dongjun Lin, MD, Liping MA, MD, Jing Sun, MD, Xiaojun Huang, MD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 3303.

https://doi.org/10.1182/blood-2019-126901

Published: 2019

Journal Articles

Preemptive Therapy Based on the Load and Time of EBV-Emia for Preventing EBV Related PTLD after Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective Multicenter Study

Can Liu, Ren Lin, Yu Wang, Fen Huang, MD, Zhiping Fan, MD, Shen Zhang, Yajing Xu, MD PhD, Ting Yang, Li Xuan, MD, Na Xu, Jieyu Ye, MD PhD, Jing Sun, Xiaojun Huang, MD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 5693.

https://doi.org/10.1182/blood-2019-132106

Published: 2019

Journal Articles

Efficacy of Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome after Allogeneic HSCT: A Multicenter Prospective Cohort Study

Shan Chen, MD, Ke Zhao, MD, Ren Lin, MD, Shunqing Wang, Zhiping Fan, MD, Fen Huang, MD, Xiaoyong Chen, PhD, Danian Nie, MD, Xin Du, MD, Ziwen Guo, MD, Dongjun Lin, MD, Li Xuan, MD, Na Xu, MD, Jing Sun, MD, Andy Peng Xiang, PhD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 871.

https://doi.org/10.1182/blood-2019-124455

Published: 2019

Journal Articles

Autologous HSCT Followed By Immunotherapy and Maintenance Chemotherapy Compared with Allogeneic HSCT for Intermediate-Risk Molecules/Cytogenetics Acute Myeloblastic Leukemia in First Complete Remission

Xiao Zhai, Li Xuan, Jing Sun, MD, Zhiping Fan, MD, Yu Zhang, Fen Huang, MD, Qianli Jiang, Dan Xu, Yongqiang Wei, Hongsheng Zhou, MDPhD, Qifa Liu, MD

Blood (2014) 124 (21): 3949.

https://doi.org/10.1182/blood.V124.21.3949.3949

Published: 2014

Journal Articles

The Prognostic Significance of Tumor-Associated Macrophages and NK Cells in Patients with Diffuse Large B-Cell Lymphoma Treated with RCHOP

Muchen Xie, MD, Yongqiang Wei, MD, Lei Yang, MD, Fen Huang, MD, Xiaolei Wei, PhD, Hui Jing, MD, Xiaoxiao Hao, Hong Zeng, PhD, Ru Feng, Pro

Blood (2014) 124 (21): 5390.

https://doi.org/10.1182/blood.V124.21.5390.5390

Published: 2014

Journal Articles

Utility of F-18 FDG PET/CT for the Diagnosis and Therapeutic Management of Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type

Bing Xu, MD, Rongwei Li, Pengcheng Shi, MD, Huijuan Dong, MD, Xutao Guo, MD, Zhiping Fan, Fen Huang, MD

Blood (2014) 124 (21): 1704.

https://doi.org/10.1182/blood.V124.21.1704.1704

Published: 2014

Journal Articles

Continuous Intravenous Injection Of Mesna Can Reduce Acute Hemorrhagic Cystitis Occurrence Rate In Hematopoietic Stem Cell Transplantation: 359 Allo-HSCT Cases Report

Blood (2013) 122 (21): 4556.

https://doi.org/10.1182/blood.V122.21.4556.4556

Published: 2013

Journal Articles

STAT3 Predicts Poor Outcome In Patients With Advanced Diffuse Large B Cell Lymphoma

Ru Feng, MD, Xiaolei Wei, Ph.D, Meng Xu, MD, Fen Huang, MD, Yongqiang Wei, Tong Zhao, B. Hilda Ye, Ph.D

Blood (2013) 122 (21): 5069.

https://doi.org/10.1182/blood.V122.21.5069.5069

Published: 2013

Journal Articles

Fungus Bloodstream Infection In Patients With Haematological Malignanciest

Ru Feng, MD, Hui Jing, MD, Yongqiang Wei, Fen Huang, MD, Yu Zhang, Xiaofang Li, Ph.D, Qi Wei, Ph.D & MD, Min Dai, PhD

Blood (2013) 122 (21): 4734.

https://doi.org/10.1182/blood.V122.21.4734.4734

Published: 2013

Journal Articles

Graft-Versus-Host Disease Following Myeloablative Busulfan Plus Fludarabine and Busulfan Plus Cyclophosphamide For Allogeneic Hematopoietic Stem Cell Transplantation In Acute Myeloid Leukemia In First Complete Remission

Qifa Liu, MD, Hui Liu, Daihong Liu, Yongrong Lai, MD, Jing Sun, MD, Chaoyang Song, Yu Zhang, Yang Xiao, MD, Fen Huang, MD, Hongsheng Zhou, Zhiping Fan, Xutao Guo, M.D., Danian Nie, MD, Guopan Yu, MD&M Sci, Xiaojun Huang

Blood (2013) 122 (21): 3290.

https://doi.org/10.1182/blood.V122.21.3290.3290

Published: 2013

Journal Articles

Sequential Intensiﬁed Conditioning Followed By Tapering Of Prophylactic Immunosupressants and Donor Lymphocyte Infusions In Allogeneic Hematopoietic Stem Cell Transplantation For Refractory Leukemia

Qifa Liu, M.D., Li Xuan, Yu Zhang, Hongsheng Zhou, Fen Huang, MD, Min Dai, Yonghua Li, Danian Nie, MD, Na Xu, Xutao Guo, M.D., Dongjun Lin, Yang Xiao, MD, Can Liu, Ph.D, Qianli Jiang, Jing Sun, MD

Blood (2013) 122 (21): 702.

https://doi.org/10.1182/blood.V122.21.702.702

Published: 2013

Journal Articles

Rituximab-Based Treatments Followed By Adoptive Cellular Therapies For EBV-Associated Post-Transplant Lymphoproliferative Disease In Recipients Of Allogeneic Hematopoietic Stem Cell Transplantation

Xinmiao Jiang, Lanping Xu, Yu Zhang, Fen Huang, MD, Daihong Liu, Jing Sun, MD, Chaoyang Song, Xinquan Liang, Zhiping Fang, Hongsheng Zhou, Min Dai, Can Liu, Ph.D, Qianli Jiang, Na Xu, Li Xuan, Meiqing Wu, Xiaojun Huang, Qifa Liu, M.D.

Blood (2013) 122 (21): 4637.

https://doi.org/10.1182/blood.V122.21.4637.4637

Published: 2013

Journal Articles

Efficacy of Chemotherapy Regimen Containing Pirarubicin on 111 Patients with High-Risk, Relapse and Refractory Acute Leukemia.

Fen Huang, MD, Fan Yi Meng, MD

Blood (2005) 106 (11): 4607.

https://doi.org/10.1182/blood.V106.11.4607.4607

Published: 2005

Journal Articles

Effects of STI571 on the Expression of c-kit Receptor in Mononuclear Cells from the Bone Marrow of Patients with Acute Non-Lymphocytic Leukemia.

Ru Feng, MD, Fen Huang, MD, Linfang Tantai, MD

Blood (2005) 106 (11): 4451.

https://doi.org/10.1182/blood.V106.11.4451.4451

Published: 2005

NARROW

Cytomegalovirus Infection in Bone Marrow-Derived Mesenchymal Stem Cells: Implications for Functions and Exploration of Relevant Mechanisms

Pre-Emptive Tyrosine Kinase-Inhibitor Intervention Based on BCR/ABL1 Monitoring in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allo-HSCT: Two Independent Observational Cohort Study

Preemptive Therapy Based on the Load and Time of EBV-Emia for Preventing EBV Related PTLD after Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective Multicenter Study

Efficacy of Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome after Allogeneic HSCT: A Multicenter Prospective Cohort Study

Autologous HSCT Followed By Immunotherapy and Maintenance Chemotherapy Compared with Allogeneic HSCT for Intermediate-Risk Molecules/Cytogenetics Acute Myeloblastic Leukemia in First Complete Remission

The Prognostic Significance of Tumor-Associated Macrophages and NK Cells in Patients with Diffuse Large B-Cell Lymphoma Treated with RCHOP

Utility of F-18 FDG PET/CT for the Diagnosis and Therapeutic Management of Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type

Continuous Intravenous Injection Of Mesna Can Reduce Acute Hemorrhagic Cystitis Occurrence Rate In Hematopoietic Stem Cell Transplantation: 359 Allo-HSCT Cases Report

STAT3 Predicts Poor Outcome In Patients With Advanced Diffuse Large B Cell Lymphoma

Fungus Bloodstream Infection In Patients With Haematological Malignanciest

Graft-Versus-Host Disease Following Myeloablative Busulfan Plus Fludarabine and Busulfan Plus Cyclophosphamide For Allogeneic Hematopoietic Stem Cell Transplantation In Acute Myeloid Leukemia In First Complete Remission

Sequential Intensiﬁed Conditioning Followed By Tapering Of Prophylactic Immunosupressants and Donor Lymphocyte Infusions In Allogeneic Hematopoietic Stem Cell Transplantation For Refractory Leukemia

Rituximab-Based Treatments Followed By Adoptive Cellular Therapies For EBV-Associated Post-Transplant Lymphoproliferative Disease In Recipients Of Allogeneic Hematopoietic Stem Cell Transplantation

Efficacy of Chemotherapy Regimen Containing Pirarubicin on 111 Patients with High-Risk, Relapse and Refractory Acute Leukemia.

Effects of STI571 on the Expression of c-kit Receptor in Mononuclear Cells from the Bone Marrow of Patients with Acute Non-Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only